GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.09.13	Event, FDA Approval, Positive Results, Partnership, and Marketing Authorization - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Lilly, and GSK (PR Newswire)
09.09.13	GSK To Sell Nutritional Drinks Lucozade, Ribena To Suntory For $2.1 Bln Cash (RTTNews)
06.09.13	Reports: Suntory In Advanced Talks To Buy GlaxoSmithKline's Drink Brands (RTTNews)
05.09.13	GSK Drug Candidate Fails To Meet First Co-primary Endpoint In Melanoma Patients (RTTNews)
05.09.13	GSK:MAGE-A3 Fails To Meet First Co-primary Endpoint In Late-stage Melanoma Trial (RTTNews)
29.08.13	M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel (PR Newswire)
23.08.13	GSK Crohn's Disease Drug Fails Trial, Licensor ChemoCentryx Stock Tanks (RTTNews)
23.08.13	ChemoCentryx Reports GSK's Top-Line Results From SHIELD-1 Phase III Trial (RTTNews)
21.08.13	Critical Alerts For American Express, Verizon Communications, GlaxoSmithKline, Archer Daniels Midland, and Quintiles Released By InvestorsObserver (PR Newswire)
21.08.13	Healthy Outlook for Healthcare Supported by Trial Milestones, Approvals, Partnerships, and Commercialization - Research Report on Lilly, Celgene, Onyx, Amgen, and GSK (PR Newswire)
16.08.13	FDA Okays Glaxo's Second Four-strain Seasonal Influenza Vaccine For Use In U.S. (RTTNews)
16.08.13	FDA Approves Additional GSK Quadrivalent Intramuscular Influenza Vaccine (RTTNews)
16.08.13	Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA (PR Newswire)
14.08.13	Before the Bell Scans: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. (PR Newswire)
14.08.13	Licenses, Phase III Trial Initiation and Results, and Investments - Research Report on Johnson & Johnson, Sanofi, AstraZeneca, Novartis, and GSK (PR Newswire)
13.08.13	UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1 (PR Newswire)
13.08.13	ViiV Healthcare Says FDA Approves HIV Drug Tivicay (RTTNews)
13.08.13	ViiV Healthcare Announces FDA Approves Tivicay For HIV-1 Treatment - Quick Facts (RTTNews)
13.08.13	ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1 (PR Newswire)
08.08.13	Regulatory Approvals, Ongoing Clinical Trials, Divestures, New Borrowings and Regulatory Applications - Research Report on Zoetis, GSK, Actavis, Kindred Healthcare, TESARO (PR Newswire)
05.08.13	GlaxoSmithKline receives FDA approval to ship four-strain (quadrivalent) influenza vaccine to healthcare providers (PR Newswire)
31.07.13	MorphoSys Posts Profit In Q2 On Higher Revenues - Quick Facts (RTTNews)
30.07.13	Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx (PR Newswire)
26.07.13	Ligand Partner GSK Receives Positive CHMP Opinion For Revolade (RTTNews)
25.07.13	Settlements, Significant Study Results, and Product Launches Lead to Advancements in Patient Care - Research Report on GSK, Isis, Endo, Pacira, and Dr. Reddy's (PR Newswire)
24.07.13	GlaxoSmithKline Quarterly Profit Declines (RTTNews)
24.07.13	GlaxoSmithKline CFO Interviewed on Q2 Results (PR Newswire)
24.07.13	GlaxoSmithKline CFO Interviewed on Q2 Results (PR Newswire)
24.07.13	GlaxoSmithKline Q2 Profit Down; Backs Full Year Outlook - Quick Facts (RTTNews)
23.07.13	Third Circuit Rules In Mylan's Favor On Paroxetine Hydrochloride ER Tablets (RTTNews)
22.07.13	GSK Says Chinese Executives May Have Breached Chinese Law (RTTNews)
22.07.13	GlaxoSmithKline Provides Update On GSK Nigeria Scheme Of Arrangement (RTTNews)
22.07.13	GSK: Senior Executives Appear To Have Broken Chinese Law (RTTNews)
16.07.13	Genentech, Biogen Idec Refused Re-hearing In Arzerra Patent Infringement Case (RTTNews)
12.07.13	GlaxoSmithKline, Theravance Provide Update On Current Japanese NDA (RTTNews)
08.07.13	WSJ: GlaxoSmithKline Probes Botox Marketing In China (RTTNews)
24.11.09	Gilead und GlaxoSmithKline geben Vereinbarung über Vermarktung von Viread® gegen chronische Hepatitis B in asiatischen Schlüsselländern bekannt (Businesswire)
03.11.09	Human Genome Sciences und GlaxoSmithKline geben positive Ergebnisse der zweiten von zwei Phase-3-Studien von BENLYSTA™ bei systemischem Lupus erythematodes bekannt (Businesswire)
03.11.09	Human Genome Sciences und GlaxoSmithKline geben positive Ergebnisse der zweiten von zwei Phase-3-Studien von BENLYSTA™ bei systemischem Lupus erythematodes bekannt (Businesswire)
20.10.09	Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at ACR of Positive Phase 3 Study Results for BENLYSTA™ in Systemic Lupus Erythematosus (Businesswire)
28.05.08	Parents: Quit Smoking and Your Children Are Less Likely to Smoke (PR Newswire)
23.05.08	Therapeutic Nicotine is Safe, Effective and Can Help Reverse Mental Acuity Deficits in Smokers Who Are Quitting, Including Commercial and Private Pilots (PR Newswire)
20.05.08	Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI) (Businesswire)
28.02.08	XenoPort and GlaxoSmithKline Report Positive Top-Line Results of Final Pivotal Trial of XP13512/GSK1838262 for Restless Legs Syndrome (Businesswire)
20.02.08	GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) (PR Newswire)
20.02.08	GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) (PR Newswire)
08.01.08	New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases (PR Newswire)
28.12.07	VIDEO from Medialink and GlaxoSmithKline: Really Think You Can 'Lose 30 Pounds in 30 Days?' (PR Newswire)
17.12.07	GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft